Related Experiment Video
Updated: Jun 1, 2025
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.4K
Improving systemic delivery of oncolytic virus by cellular carriers
Ziyi Peng1, Muhammad Kalim1, Yong Lu1
1Houston Methodist Cancer Center/Weill Cornell Medicine, Houston, TX 77030, USA.
Cancer Biology & Medicine
|January 20, 2025
Summary
Oncolytic virotherapy (OVT) uses viruses to target cancer cells, but delivery to solid tumors is challenging. Cellular carriers are being explored to improve oncolytic virus (OV) delivery and enhance cancer treatment efficacy.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Oncolytic virotherapy (OVT) shows promise for cancer treatment by selectively replicating oncolytic viruses (OVs) in cancer cells, stimulating anti-tumor immune responses.
- Key challenges in OVT include insufficient tumor-specific targeting, limited tumor penetration, and variable efficacy, especially in complex solid tumor microenvironments.
Purpose of the Study:
- To review current strategies for enhancing oncolytic virus (OV) delivery using cellular carriers.
- To explore how cellular carriers can improve OV distribution within tumor microenvironments for optimized immune activation and anti-tumor effects.
Main Methods:
- Review of existing research on cellular carrier-mediated delivery of oncolytic viruses (OVs).
- Analysis of strategies aimed at improving OV targeting, penetration, and efficacy within solid tumors.
Main Results:
- Cellular carriers show potential for improving the delivery and distribution of OVs in tumor microenvironments.
- Enhanced delivery via cellular carriers may optimize immune system activation and maximize anti-tumor effects.
Conclusions:
- Improving OV delivery through cellular carriers is crucial for enhancing the clinical impact of oncolytic virotherapy (OVT).
- Further research into cellular carrier strategies is needed to overcome OVT challenges and improve cancer treatment outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K